Total Payments
$624.73
2018 Payments
$364.23
Companies
10
Transactions
20
Medicare Patients
426
Medicare Billing
$98,675
Payment Breakdown by Category
Food & Beverage$624.73 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $624.73 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $324.65 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $124.06 | 1 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $38.75 | 2 | $0 (2018) |
| Chiesi USA, Inc. | $22.49 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $22.00 | 1 | $0 (2018) |
| Scilex Pharmaceuticals Inc. | $21.79 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $20.59 | 1 | $0 (2018) |
| Lundbeck LLC | $19.63 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $16.87 | 1 | $0 (2018) |
| Pernix Therapeutics Holdings, Inc. | $13.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $364.23 | 12 | Janssen Pharmaceuticals, Inc ($124.06) |
| 2017 | $260.50 | 8 | Teva Pharmaceuticals USA, Inc. ($260.50) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2018 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Analgesic | ||||||
| 12/18/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Central Nervous System | ||||||
| 10/31/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 06/28/2018 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: Respiratory | ||||||
| 06/13/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/31/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/31/2018 | Pernix Therapeutics Holdings, Inc. | SILENOR (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: NEUROLOGY | ||||||
| 05/30/2018 | Chiesi USA, Inc. | CARDENE (Drug), CLEVIPREX, KENGREAL | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2018 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CNS | ||||||
| 03/31/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $124.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Respiratory | ||||||
| 09/20/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Respiratory | ||||||
| 05/15/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Respiratory | ||||||
| 05/15/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $35.98 | General |
| Category: Respiratory | ||||||
| 04/03/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Respiratory | ||||||
| 04/03/2017 | Teva Pharmaceuticals USA, Inc. | QVAR (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: Respiratory | ||||||
| 01/23/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Respiratory | ||||||
| 01/23/2017 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 114 | 308 | $85,792 | $32,293 |
| 2022 | 8 | 210 | 333 | $58,243 | $21,417 |
| 2021 | 2 | 53 | 188 | $56,166 | $19,093 |
| 2020 | 2 | 49 | 238 | $71,400 | $25,873 |
Total Patients
426
Total Services
1,067
Medicare Billing
$98,675
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 44 | 238 | $77,595 | $28,700 | 37.0% |
| 90662 | Influenza vaccine split virus, preservative free | Facility | 2023 | 34 | 34 | $4,994 | $2,446 | 49.0% |
| G0008 | Administration of influenza virus vaccine | Facility | 2023 | 36 | 36 | $3,203 | $1,147 | 35.8% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 35 | 127 | $36,988 | $11,641 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Facility | 2022 | 35 | 35 | $4,797 | $2,399 | 50.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 33 | $2,625 | $1,552 | 59.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $2,467 | $1,234 | 50.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 14 | 19 | $2,852 | $1,065 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Facility | 2022 | 32 | 32 | $2,747 | $990.72 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 13 | $1,905 | $977.86 | 51.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 15 | 20 | $1,901 | $709.60 | 37.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $1,631 | $588.24 | 36.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 17 | $332.35 | $260.61 | 78.4% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 40 | 175 | $51,463 | $17,406 | 33.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 13 | 13 | $4,703 | $1,686 | 35.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 38 | 227 | $67,362 | $24,387 | 36.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 11 | 11 | $4,039 | $1,486 | 36.8% |
About Dr. Theodor Parada, M.D
Dr. Theodor Parada, M.D is a Critical Care Medicine healthcare provider based in Daly City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568452704.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodor Parada, M.D has received a total of $624.73 in payments from pharmaceutical and medical device companies, with $364.23 received in 2018. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($624.73).
As a Medicare-enrolled provider, Parada has provided services to 426 Medicare beneficiaries, totaling 1,067 services with total Medicare billing of $98,675. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Surgery, Hospitalist
- Location Daly City, CA
- Active Since 10/27/2005
- Last Updated 11/18/2017
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568452704
Products in Payments
- QVAR (Drug) $229.11
- INVOKANA (Drug) $124.06
- PROAIR (Drug) $63.88
- LifeVest (Device) $38.75
- AJOVY (Drug) $31.66
- CARDENE (Drug) $22.49
- PRALUENT ALIROCUMAB INJECTION (Biological) $22.00
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $21.79
- APTIOM (Drug) $20.59
- NORTHERA (Drug) $19.63
- BRILINTA (Drug) $16.87
- SILENOR (Drug) $13.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.